酸盐激酶在头癌发生过程中差异地改变代谢特征
Pei-Chun Huang1, Ching-Wen Chang2,3, Yu-Cheng Lin4,5
1Institute of Oral Biology, College of Dentistry, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
International journal of molecular sciences
|December 9, 2023
概括
酸盐激酶PKM2,典型的致癌性,在头癌中起到瘤抑制作用. 损失PKM2通过改变新陈代谢和激活癌症信号通路,促进瘤生长和对西斯普拉丁的抵抗.
科学领域:
- 生物化学 生化学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 酸盐激酶M2 (PKM2) 在糖解过程中对ATP产生至关重要.
- 在各种癌症中,PKM2通常被认为是瘤促进剂.
- 对于PKM2在头部和部状细胞癌 (HNSC) 致癌的特定作用,需要进一步研究.
研究的目的:
- 研究PKM2在头癌发生过程中的表达和功能.
- 确定PKM2对HNSC恶性瘤,瘤生长和治疗反应的影响.
- 阐明PKM2在HNSC中的作用背后的分子机制.
主要方法:
- 在HNSC组织中分析PKM2mRNA和蛋白质表达.
- 在HNSC细胞系中使用shRNA介导PKM2敲击的功能研究.
- 在体内进行异种移植瘤生长测试和对西斯普拉丁耐药性的评估.
- 对代谢转变和信号通路激活 (Akt,ERK) 的分析.
主要成果:
- 在HNSC组织中,PKM2表达升高,但较高的mRNA水平与较低的瘤阶段和更好的存活率相关.
- 在体内,PKM2 缺乏导致瘤生长的增加和对西斯普拉丁的耐药性.
- 抑制PKM2会降低细胞的运动性.
- 损失PKM2诱导了对线粒体代谢的代谢重编程,并激活了Akt/ERK信号传递.
结论:
- 与其在其他癌症中的作用相反,PKM2在HNSC中表现出瘤抑制功能.
- 通过代谢重编程和关键信号通路的调节,PKM2调节头部和部瘤性.
- 准PKM2或其下游途径可能为HNSC提供新的治疗策略.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20Fates of Pyruvate
8.5K
Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
8.5K